Simone Jouquey
31 works · 1,204 citations · h-index 13
Top works
- Release of prostaglandins E and F in an algogenic reaction and its inhibition
- 4-Hydroxy-3-quinolinecarboxamides with antiarthritic and analgesic activities
- Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
- Inhibition of prostaglandin biosynthesis by non-narcotic analgesic drugs.
- Trandolapril Decreases Prevalence of Ventricular Ectopic Activity in Middle-Aged SHR
- Structure-activity relationship in PAF-acether. 3. Hydrophobic contribution to agonistic activity
- Cardiovascular Actions and Tissue-Converting Enzyme Inhibitory Effects of Chronic Enalapril and Trandolapril Treatment of Spontaneously Hypertensive Rats
- Kappa Agonists and Vasopressin Secretion
- Compared Properties of Trandolapril, Enalapril, and Their Diacid Metabolites
- Effect of chronic treatment with trandolapril or enalapril on brain ACE activity in spontaneously hypertensive rats
- Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat
- Compared Properties of Trandolapril, Enalapril, and Their Diacid Metabolites
- Regression of Left Ventricular Hypertrophy by Converting Enzyme Inhibition in 12–15-Month-Old Spontaneously Hypertensive Rats
- Structure-activity relationship in PAF-acether. 4. Synthesis and biological activities of carboxylate isosteres
- Effects of Subchronic Treatment with Trandolapril and Enalapril on Cardiovascular Morphologic Alterations in the Aged Spontaneously Hypertensive Rat with Heart Failure
- A sensitive reverse transcriptase polymerase chain reaction assay for measuring the effects of dehydration and gestation on rat amounts of vasopressin and ocytocin mRNAs
- Trandolapril Dose-Response in Spontaneously Hypertensive Rats
- Study of the Vasodilating Activity of Salbutamol on Dog Coronary Arteries
- Trandolapril Dose-Response in Spontaneously Hypertensive Rats
- PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.